Sanofi Pasteur;Centers for Disease Control and Prevention
发明人:
Richard KINNEY,Claire Y.H. Kinney,Veronique Barban,Jean Lang,Bruno Guy
申请号：
US14450529
公开号：
US20150031857A1
申请日:
2014.08.04
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV2 strain.
